Abstract
[R,S]-5-formyltetrahydrofolate (5-CHOFH4) has shown significant potentiation of fluorouracil (FU) activity in colorectal, breast, and head and neck cancer.1–7 The biochemical basis for this enhanced activity is metabolic conversion of 5-CHOFH4 to 5,10-methylenetetrahydrofolate (CH2FH4) which in turn stabilizes the inhibitory complex formed between the active metabolite of fluorouracil, 5-fluoro-2-deoxyuridine-5’-monophosphate (FdUMP), and thymidylate synthase. This inhibition results in depletion of thymidylate required for DNA synthesis and repair.8–11
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
E. Mini, F. Trave, Y.M. Rustum, and J.R. Bertino, Enhancement of the antitumor effects of 5-fluorouracil by folinic acid, Pharmacol. Ther. 47:1 (1990).
S. Madajewicz, N.J. Petrelli, Y.M. Rustum, J. Campbell, L. Herrera, A.Mittelman, A. Perry, and P.J. Creaven, A phase I-II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer, Cancer Res. 44:4667 (1984).
N.J. Petrelli, Y.M. Rustum, H. Bruckner, and D. Stablein, The Roswell Park Memorial Institute and Gastrointestinal Tumor Study Group phase III experience with the modulation of 5-fluorouracil by leucovorin in metastatic colorectal adenocarcinoma, Adv. Exp. Med. Biol. 244:143 (1988).
L.R., Laufman, K.A. Krzeczowski, R. Roach, and M. Segal, Leucovorin plus 5-fluorouracil: An effective treatment for metastatic colon cancer, J. Clin. Oncol. 5:1394(1987).
J.H. Doroshow, L. Leong, K. Margolin, B. Flanagan, D. Goldberg, M. Bertram,S. Akman, B. Carr, O. Odujinrin, E. Newman, and T. Lichtfield, Refractory metastatic breast cancer: Salvage therapy with fluorouracil and high-dose continuous infusion leucovorin calcium, J. Clin. Oncol. 7:439(1989).
S.M. Swain, M.E. Lippman, E.F. Egan, J.C. Drake, S.M. Steinberg and C.J.Allegra, Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer, J. Clin. Oncol. 7:890 (1989).
E.E. Vokes, K.E. Choi, R.L. Schilsky, R.J. Moran, C.M. Guarnieri, R.R.Weichselbaum, and W.R. Panje, Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer, J. Clin. Oncol. 6:618 (1988).
P.V. Danenberg and K.D. Danenberg, Effect of 5,10-methylenetetrahydrofolate on the dissociation of 5-fluoro-2’-deoxyuridylate from thymidylate synthetase: Evidence for an ordered mechanism, Biochemistry 17:4018 (1978).
B. Ullman, M. Lee, D.W. Martin, Jr., and D.V. Santi, Cytotoxicity of 5-fluoro-2’-deoxyuridine: Requirement for reduced folate cofactors and antagonism by methotrexate., Pro. Natl. Acad. Sci. USA 75:980 (1978).
J.A. Houghton, C. Schmidt, and P.J. Houghton, The effect of derivatives of folic acid on the fluorodeoxyuridylate-thymidylate synthetase covalent complex in human colon xenografts, Eur. J. Cancer Clin. Oncol. 18:347 (1982).
R.M. Evans, J.D. Laskin, and M.T. Hakala, Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil, Cancer Res. 41:3288(1981).
D.G. Priest, J.C. Schmitz, M.A. Bunni, and R.K. Stuart, Pharmacokinetics of leucovorin metabolites in human plasma as a function of dose administered orally and intravenously, J. Natl. Cancer Inst. 83:1806 (1991).
M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding, Anal. Biochem. 72:248 (1976).
D.G. Priest and M.T. Doig, Tissue folate polyglutamate chain length determination by electrophoresis as thymidylate synthase-fluorodeoxyuridylate ternary complexes, Methods Enzymol. 122:313 (1986).
D.G. Priest, C.D. Veronee, M. Mangum, J.M. Bednark, and M.T. Doig, Comparison of folypolyglutamate hydrolases of mouse liver, kidney, muscle, and brain, Mol. Cell. Biochem. 43:81, (1982).
M.T. Doig, J.R. Peters, P. Sur, M. Dang, and D.G. Priest, Determination of mouse liver 5-methyltetrahydrofolate concentration and polyglutamate forms, J. Biochem. Biophys. Methods 10:287 (1985).
V. Kesavan, M.T. Doig, and D.G. Priest, A radioenzymatic method for the determination of tissue 10-formyltetrahydofolate, J. Biochem. Biophys. Methods 12:311 (1986).
D.G. Priest, M.A. Bunni, L.R. Romero-Fredes, J.C. Schmitz, and J.M. Whiteley, A sensitive radioenzymatic assay for [S]5-formyltetrahydrofolate, Anal. Biochem. 196:284(1991).
D.V. Santi, C.S. McHenry, and E.R. Perriard, A filter assay for thymidylate synthetase using 5-fluoro-2’-deoxyuridylate as an active site tirant, Biochem. 13:467 (1974).
R.L. Schilsky and M.J. Ratain, Clinical pharmacokinetics of high-dose leucovorin calcium after intravenous and oral administrations, J. Natl. Cancer Inst. 82:1411 (1990).
A. Schalhorn, M. Kühl, G. Stupp-Poutot, and V. Ntissler, Pharmacokinetics of reduced folates after short-term infusion of d, 1-folinic acid, Cancer Chemother. Pharmacol. 25:440 (1990).
E. Mini, T. Mazzei, M. Coronnello, L. Criscuoli, M. Gualtieri, P. Periti, and J.R. Bertino, Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cells, Biochem. Pharmac. 36:2905 (1987).
J.A. Houghton, L.G. Williams, S.S.N. DeGraff, P.J. Cheshice, I.W. Waina, P. Jadand, and P.J. Houghton, Comparision of the conversion of 5-formyltetrahydrofolate and 5-methyltetrahydrofolate to 5,10-methylenetetrahydrofolate and tetrahydrofolate in human colon tumors, Cancer Comm. 1:167(1989).
P. La Ciura, G. La Grotta, and E. Nigra, A. Comandone, G. Grecchi, G. Leria,and A. Calciati, 5-Methyltetrahydrofolic acid (MFH4): An effective folate for the treatment of advanced colorectal cancer with 5-FU, Recent Results in Cancer Res. 110: 219 (1988).
C. Erlichman, S. Fine, A. Wong, and T. Elhakim, A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma, J. Clin. Oncol. 6:469 (1988).
M.A. Poon, M.J. O’Connell, H.S. Wieand, J.E. Krook, J.B. Gerstner, L.K. Tschetter, R. Levitt, C.G. Kardinal, and J.A. Mailliard, Biochemical modulation of fluorouracil with leucovorin: Confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer, J. Clin. Oncol. 9:1967(1991).
L.R. Laufman, W.D. Brenckman, Jr., and K.A. Stydnicki, Clinical experience with leucovorin and 5-fluorouracil, Cancer 63:103 (1989).
J.D. Hines, D.J. Adelstein, J.L. Spiess, P. Girowski, and S.G. Carter, Efficacy of high-dose oral leucovorin and 5-fluorouracil in advanced colorectal carcinoma, Cancer 63:1022 (1989).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Priest, D.G., Schmitz, J.C., Bunni, M.A. (1993). Folate Metabolites as Modulators of Antitumor Drug Activity. In: Ayling, J.E., Nair, M.G., Baugh, C.M. (eds) Chemistry and Biology of Pteridines and Folates. Advances in Experimental Medicine and Biology, vol 338. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2960-6_143
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2960-6_143
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6287-6
Online ISBN: 978-1-4615-2960-6
eBook Packages: Springer Book Archive